Last October, the Nagoya Protocol entered into force for all signing parties as an international agreement...
CURRENT ISSUES
Most life sciences firms pursuing R&D have tried at some point to slip sideways out of the traditional...
The past six months saw many European life sciences companies successfully cashing in substantial amounts to...
It’s been less than a decade since Nobel laureate Shinya Yamanaka first reprogrammed human cells to return to...
Mining has traditionally been energy-intensive and not exactly great for the environment. But innovative...
Although the worldwide vaccine market has experienced double-digit growth for years, the vaccine industry...
Share
